Clinical Hand Findings in 240 Final-Year Apprentice Nurses
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: How did examination, self-report and allergy testing differ in apprentice nurses?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 240 final-year apprentice nurses in Zagreb vocational schools; 75% were female and median age was 19 years. |
| Design | Questionnaire plus clinical OHSI examination; 42 participants with hand eczema lasting over three months underwent prick and patch testing. |
| Comparator | Participants with clinically observed changes versus healthy skin, plus clinical versus self-reported frequency. |
| Timepoint | 2020-2021. |
| Key result | Clinically observed and self-reported hand eczema were 49% and 46%, respectively. Among 42 tested participants there were no positive latex prick tests, while 11 (26%) had at least one positive patch-test reaction, mostly to nickel. |
| Funding/conflict context | The indexed abstract does not state funding or conflicts. No branded moisturizer was studied. |
What was actually measured?
Clinically observed and self-reported hand eczema were 49% and 46%, respectively. Among 42 tested participants there were no positive latex prick tests, while 11 (26%) had at least one positive patch-test reaction, mostly to nickel.
The testing denominator was 42, not all 240. Nickel positivity identifies sensitization and does not by itself establish that nickel caused each hand condition.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
Pandemic-period exposures, selected final-year students, limited patch testing to persistent cases and cross-sectional data restrict generalization.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 34773266
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Work Relevance Across 250 Dermatitis Disability Claims
- Standard and Additional Patch Tests Across 937 Patients
- Hand-Eczema Signs Reported by 863 Northern Italian Hospital Workers
- Hand Findings Across 229 Japanese Spine-Surgery Respondents
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.